Listas Anotadas de Medicamentos e Dispositivos
| Listas | Seção | Observação |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Outras observações: FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children |
| Listas | Seção | Observação |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines |
Este medicamento requer um especialista para uso em crianças Outras observações: Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. For use only in combination with meropenem or imipenem+cilastatin. |
| Peru | 6.2.1.1 Penicillins | Sem observações |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | Sem observações |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Outras observações: FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children |
| Listas | Seção | Observação |
|---|---|---|
| Chile | Essential and Prioritized Medications | Sem observações |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | Sem observações |
| Listas | Seção | Observação |
|---|---|---|
| Chile | Essential and Prioritized Medications | Sem observações |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Outras observações: FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children |
| Listas | Seção | Observação |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Outras observações: FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children |
| Listas | Seção | Observação |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 6.2.5. Antituberculosis medicines |
Outras observações: Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control. For use only in combination with meropenem or imipenem+cilastatin. |
| PAHO Strategic Fund Medicine List | 2.1. Antibacterial | Sem observações |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Outras observações: FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children |
| Listas | Seção | Observação |
|---|---|---|
| Chile | Essential and Prioritized Medications | Sem observações |
| WHO Model List of Essential Medicines (2021) | 6.2.1. Access group antibiotics |
Outras observações: FIRST CHOICE − Community acquired pneumonia (severe) [c] − Complicated intraabdominal infections (mild to moderate) − Exacerbations of COPD − Hospital acquired pneumonia − Low-risk febrile neutropenia − Lower urinary tract infections − Sinusitis − Skin and soft tissue infections SECOND CHOICE − Bone and joint infections − Community-acquired pneumonia (mild to moderate) − Community acquired pneumonia (severe) − Otitis media − Surgical prophylaxis [c]: only for children |